Pradžia › Širdies nepakankamumas › Washington › Seattle
Širdies nepakankamumas klinikiniai tyrimai Seattle, WA
17 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Seattle ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Renkami dalyviai3 fazė
- Virginia Mason Medical Center, Seattle
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Renkami dalyviai2 fazė
- Local Institution - 132, Seattle
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Renkami dalyviai2/3 fazė
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Renkami dalyviai2 fazė
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Renkami dalyviaiStebimasis tyrimas
- Virginia Mason Medical Center, Seattle
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Renkami dalyviai3 fazė
- Tenax Investigational Site, Seattle
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Renkami dalyviai3 fazė
- Swedish Medical Center_Seattle, Seattle
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Renkami dalyviai2 fazė
- Seattle Children's Hospital, Seattle
Assessment of CCM in HF With Higher Ejection Fraction
Renkami dalyviai
- Swedish Medical Center, Seattle
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Renkami dalyviai2 fazė
- University of Washington Medical Center, Seattle
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Renkami dalyviai3 fazė
- University of Washington, Seattle
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Renkami dalyviai
- University of Washington Medical Center, Seattle
Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
Renkami dalyviai
- University of Washington, Seattle
Left vs Left Randomized Clinical Trial
Renkami dalyviai
- University of Washington, Seattle
Cardiogenic Shock Working Group Registry
Renkami dalyviaiStebimasis tyrimas
- University of Washington Medical Center, Seattle
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Renkami dalyviai1/2 fazė
- University of Washington Medicine, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Renkami dalyviai
- University of Washington Medical Center, Seattle
Širdies nepakankamumas tyrimai kituose miestuose
- New York City, NY51 tyrimas
- Boston, MA44 tyrimai
- Dallas, TX42 tyrimai
- Houston, TX36 tyrimai
- Cleveland, OH33 tyrimai
- Chicago, IL31 tyrimas
- Philadelphia, PA31 tyrimas
- San Francisco, CA29 tyrimai
- St. Louis, MO26 tyrimai
- Durham, NC26 tyrimai
- Kansas City, MO25 tyrimai
- Atlanta, GA25 tyrimai
Kiti tyrimai Seattle
- Nedidelinių ląstelių plaučių vėžys53 tyrimai
- Vėžys (visų tipų)49 tyrimai
- Prostatos vėžys42 tyrimai
- Ūmi mieloidinė leukemija40 tyrimai
- Krūties vėžys39 tyrimai
- Metastatinis vėžys39 tyrimai
- Storosios ir tiesiosios žarnos vėžys34 tyrimai
- Plaučių vėžys33 tyrimai
- Kiaušidžių vėžys30 tyrimai
- Kartotinė mieloma22 tyrimai
- Mielodisplastiniai sindromai21 tyrimas
- Ūmi limfoblastinė leukemija21 tyrimas
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.